Lilly touts plan to overcome key patent losses
Lilly touts plan to overcome key patent losses
Eli Lilly & Co. stands months away from losing patent protection for its top-selling drug and is telling investors the keys to overcoming this and other patent losses lie in its own labs and emerging markets like China.